Diamond Medino Capital
Overview
Diamond Medino Capital is a venture capital firm based in Tokyo, Japan, that specializes in investing in and providing hands-on support to healthcare-related venture companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Global Vascular Co., Ltd. | Jun 2025 | Series B | Co-investor |
| Spine Chronicle Japan Co., Ltd. | Jan 2025 | Series A | Lead |
| F.MED Co., Ltd. | Jul 2024 | Series A | Lead |
| StapleBio, Inc. | Apr 2024 | VC Round | Lead |
| FerroptoCure Inc. | Sep 2025 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Diamond Medino Capital based?
Diamond Medino Capital is headquartered in Tokyo, Japan.
When was Diamond Medino Capital founded?
Diamond Medino Capital was founded in 2022.
How many portfolio companies does Diamond Medino Capital have?
Diamond Medino Capital has 5 portfolio companies in Caplight's dataset.
What are some companies in Diamond Medino Capital's portfolio?
Portfolio companies visible on Caplight include Global Vascular Co., Ltd., Spine Chronicle Japan Co., Ltd., F.MED Co., Ltd., StapleBio, Inc., FerroptoCure Inc..
What was Diamond Medino Capital's most recent investment shown here?
Diamond Medino Capital's most recent investment in this portfolio sample was in FerroptoCure Inc. in 2025.
What sectors does Diamond Medino Capital focus on?
Diamond Medino Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Diamond Medino Capital focus on?
Diamond Medino Capital typically invests at the Early stage.
What is Diamond Medino Capital's AUM?
Diamond Medino Capital's assets under management are estimated between $17.2M and $17.2M.